Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026)
Bausch & Lomb (BLCO) posted Other Non-Current Assets of $302.0 million for Q1 2026, down 2.58% on a QoQ basis from $310.0 million in Q4 2025, and up 2.37% year-over-year from $295.0 million in Q1 2025.
Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $302.0 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 2.37% year-over-year to $302.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $302.0 million (up 2.37% YoY) and the FY2025 annual result came in at $310.0 million, up 5.44% from the prior year.
- Other Non-Current Assets was $302.0 million for Q1 2026 at Bausch & Lomb, down from $310.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $310.0 million in Q3 2024 and bottomed at $188.0 million in Q1 2022.
- A 5-year average of $253.5 million and a median of $231.0 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets retreated 7.02% — and 2024, when it soared 46.23%.
- Bausch & Lomb's Other Non-Current Assets stood at $215.0 million in 2022, then rose by 4.65% to $225.0 million in 2023, then jumped by 30.67% to $294.0 million in 2024, then advanced by 5.44% to $310.0 million in 2025, then fell by 2.58% to $302.0 million in 2026.
- Business Quant data shows BLCO's Other Non-Current Assets at $302.0 million in Q1 2026, $310.0 million in Q4 2025, and $303.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | 302.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302.00 Mn |
| Dec 31, 2025 | 310.00 Mn |
| Sep 30, 2025 | 303.00 Mn |
| Jun 30, 2025 | 305.00 Mn |
| Mar 31, 2025 | 295.00 Mn |
| Dec 31, 2024 | 294.00 Mn |
| Sep 30, 2024 | 310.00 Mn |
| Jun 30, 2024 | 249.00 Mn |
| Mar 31, 2024 | 231.00 Mn |
| Dec 31, 2023 | 225.00 Mn |
| Sep 30, 2023 | 212.00 Mn |
| Jun 30, 2023 | 207.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | 215.00 Mn |
| Sep 30, 2022 | 228.00 Mn |
| Jun 30, 2022 | 222.00 Mn |
| Mar 31, 2022 | 188.00 Mn |
| Dec 31, 2021 | 180.00 Mn |